Adeno-associated virus vectors for vascular gene delivery

Circulation Research

Volumn 80, Issue 4, 1997, Pages 497-505

  Lynch, Carmel M ^b   Hara, Paul S ^c   Leonard, Jill C ^c   Williams, J Koudy ^a   Dean, Richard H ^a   Geary, Randolph L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Targeted Genetics Corporation   (United States)

^c NONE

Author keywords

adeno associated virus; cynomolgus monkey; endothelial cell; gene transfer; microvessel

Indexed keywords

ALKALINE PHOSPHATASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; MACACA; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT;

ANIMALS; CAROTID ARTERY, COMMON; CELLS, CULTURED; DEPENDOVIRUS; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MALE; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; RABBITS; RATS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 0030912001     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990:249;1285-1288.
2. Takeshita S, Losordo DW, Kearney M. Rossow ST, Isner JM. Time course of recombinant protein secretion after liposome-mediated gene transfer in a rabbit arterial organ culture model, Lab Invest. 1994;71:387-391.
3. Lemarchand P, Jones M. Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993;72:1132-1138.
4. Schuljck AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation. 1995;91:2407-2414.
5. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, Proc Natl Acad Sci U S A. 1994;91:4407-4411.
6. Newman KD, Dunn PF, Qwens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia, J Clin Invest. 1995;96:2955-2965.
7. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol. 1992;158:97-129.
8. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther. 1994;5:793-801.
9. Carter BJ. Adeno-associatcd virus vectors. Curr Opin Biotechnol. 1992;3:533-539.
10. Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy, Gene Ther. 1995;2:357-362.
11. Chatterjee S, Johnson PR, Wong KK Jr. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector, Science, 1992;258:1485-1488.
12. - channels by protein kinase A corrected by insertion of CFTR. Nature. 1992;358:581-584. Comments.
13. Flotte TR, Solow R, Owens RA, Afione S, Zeillin PL, Carter BJ. Gene expression from adeno-associated virus vectors in airway epithelial cells. Am J Respir Cell Mol Biol. 1992;7:349-356.
14. Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector, Proc Natl Acad Sci USA. 1992;89:7257-7261.
15. Flotte TR, Afione SA, Solow R, Drumm ML, Markakis D, Guggino WB, Zeitlin PL, Carter BJ. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem. 1993;268:3781-3790.
16. Miller JL, Walsh CE, Ney PA, Samulski RJ, Nienhuis AW. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer [published erratum appears in Blood. 1995:85:862]. Blood. 1993;82:1900-1906.
17. Flotte TR, Afione SA, Zeitlin PL. Adeno-assoeiated virus vector gene expression occurs In nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol. 1994;11:517-521.
18. Halbert CL, Alexander IE, Wolgamot GM, Miller AD, Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells, J Virol. 1995;69:1473-1479.
19. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zetilin PL, Guggino WB, Carter BJ. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci U S A. 1993;90:10613- 10617.
20. Russell DW, Miiler AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci U S A. 1994;91:8915-8919.
21. Muro-Cacho CA, Samulski RJ, Kaplan D. Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immunother. 1992;11:231-237.
22. Zhou SZ, Broxmeyer HE, Cooper S, Harrington MA, Srivastava A. Adeno-associated virus 2-mediitted gene transfer in murine hematopoietic progenitor cells. Exp Hematol. 1993;21:928-933.
23. Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW, Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells [published erratum appears in Blood. 1995;85:862]. Blood. 1994;84:1492-1500.
24. Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE, Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med. 1994;179:1867-1875.
25. Fisher KJ, Gao GP, Weitznwn MD, De Matteo R, Burda JF, Wilson JM. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J Virol. 1996;70:520-532.
26. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994;8:148-154.
27. Conrad CK, Allen SS, Afione SA, Reynolds TC, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR, Stable in vivo CFTR gene transfer to the primate lung using adeno-associated virus vectors: safety of single-dose administration. Gene Ther. 1996;3:658-668.
28. Jaffe EA, Nachman RL, Becker CG, Minick CR, Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
29. Lynch CM, Clowes MM, Osborne WR, Clowes AW, Miller AD. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci U S A. 1992;89:1138-1142.
30. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, Kieffer KA, Craig R, Guggino WB. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol. 1991;4:313-319.
31. Fields-Berry SC, Halliday AL, Cepko CL. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc Natl Acad Sci U S A. 1992;89:693-697.
32. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 1996;41:521-530.
33. Levitt N, Briggs D, Gil A, Proudfoot NJ. Definition of an efficient synthetic poly(A) site. Genes Dev. 1989;3:1019-1025.
34. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest. 1994;93:644-651.
35. Wang X, Ponnazhagan S, Srivastava A. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J Virol. 1996;70:1668-1677.
36. Sumulski RJ, Srivastava A, Berns KI, Muzyczka N. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell. 1983;33:135-143.
37. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR. In vivo model of adeno-associated virus vector persistence and rescue. J Virol. 1996;70:3235-3241.
38. Flotte TR, Barraza-Ortiz X, Solow R, Afione SA, Carter BJ, Guggino WB, An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 1995;2:29-37.
39. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis: a nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol. 1996;16:34-43.
40. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodeling of coronary arteries in human and nonhuman primates. JAMA. 1994;271:289-294. Comments.
41. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
42. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall; modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 1994;14:148-161.
43. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 1993;88:2838-2848.